T. Warkentin

New England Journal of Medicine · 2001–2021

A researcher in the Science corpus: 7 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Whom T. Warkentin trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Stam

Who trusts T. Warkentin overall

  1. Gustavo Saposnik

Papers from T. Warkentin's perspective

Ordered by how strongly the researchers T. Warkentin trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association (Stroke)
  2. Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues (Annals of Internal Medicine)
  3. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. (New England Journal of Medicine)
  4. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. (Chest)
  5. Nonparametric Estimation from Incomplete Observations
  6. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. (Journal of the American Medical Association (JAMA))
  7. Incidence and predictors of severe obstetric morbidity: case-control study. (British medical journal)
  8. Temporal aspects of heparin-induced thrombocytopenia. (New England Journal of Medicine)
  9. Bivalirudin for patients with acute coronary syndromes. (New England Journal of Medicine)
  10. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. (The Lancet)

Their papers